News
August 2026
2artifacts
News
🔬 Emerging Technology Watch
Merck and Moderna's personalized mRNA cancer vaccine, intismeran autogene, met the main goal of its pivotal Phase 3 trial in melanoma — the first pivotal success for the modality — Piloting / trials.
2026-08-20 emerging-tech
News
🔬 Emerging Technology Watch
OpenAI previewed "Ultrafast," a mode that runs flagship model GPT-5.6 Sol at 14x speed, aimed squarely at enterprise workloads — Piloting / trials
2026-08-13 emerging-tech